Perspective Therapeutics, Inc.

CATX XASE • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

330M

Short interest (Jul 15)

20.0%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.29%

↑ 0.1%

Available Shares

300K

↓ 83.1%

Price Chart

Company Overview

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Company Info

Exchange: XASE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0000728387

Asset Type: CS

Market Data

Market Cap: $331,874,433

Employees: 166

Status: Active

Short Interest

Current Borrow Fee 0.29%

Range: 0.29% - 0.29%

Available Shares 300K

Range: 300K - 300K

Recent Changes

Fee Change: ↓ 0.8%

Available Change: ↑ 8.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime